Hassan Ameer E, Shamim Hafsah, Zacharatos Haralabos, Chaudhry Saqib A, Sanchez Christina, Tekle Wondwossen G, Sanchez Olive, Abantao Erlinda, Qureshi Adnan I
Valley Baptist Medical Center, Harlingen, Texas, USA.
Department of Neurology, University of Texas Rio Grande Valley, Edinburg, Texas, USA.
Interv Neurol. 2020 Jan;8(2-6):116-122. doi: 10.1159/000496615. Epub 2019 Feb 28.
Studies have shown a lack of agreement of computed tomography perfusion (CTP) in the selection of acute ischemic stroke (AIS) patients for endovascular treatment.
To demonstrate whether non-contrast computed tomography (CT) within 8 h of symptom onset is comparable to CTP imaging.
Prospective study of consecutive anterior circulation AIS patients with a National Institute of Health Stroke Scale (NIHSS) score > 7 presenting within 8 h of symptom onset with endovascular treatment. All patients had non-contrast CT, CT angiography, and CTP. The neuro-interventionalist was blinded to the results of the CTP and based the treatment decision using the Alberta Stroke Program Early CT score (ASPECTS). Baseline demographics, co-morbidities, and baseline NIHSS scores were collected. Outcomes were modified Rankin scale (mRS) score at discharge and in-hospital mortality. Good outcomes were defined as a mRS score of 0-2.
283 AIS patients were screened for the trial, and 119 were enrolled. The remaining patients were excluded for: posterior circulation stroke, no CTP performed, could not obtain consent, and NIHSS score < 7. Mean -NIHSS score at admission was 16.8 ± 3, and mean ASPECTS was 8.4 ± 1.4. There was no statistically significant correlation with CTP penumbra and good outcomes: 50 versus 47.8% with no penumbra present ( = 0.85). In patients without evidence of CTP penumbra, there was 22.5% mortality compared to 22.1% mortality in patients with a CTP penumbra. If ASPECTS ≥7, 64.6% had good outcome versus 13.3% if ASPECTS < 7 ( < 0.001). Patients with an ASPECTS ≥7 had 10% mortality versus 51.4% in patients with an ASPECTS < 7 ( < 0.001).
CTP penumbra did not identify patients who would benefit from endovascular treatment when patients were selected with non-contrast CT ASPECTS ≥7. There is no correlation of CTP penumbra with good outcomes or mortality. Larger prospective trials are warranted to justify the use of CTP within 6 h of symptom onset.
研究表明,在选择急性缺血性卒中(AIS)患者进行血管内治疗时,计算机断层扫描灌注(CTP)结果存在差异。
证明症状发作8小时内的非增强计算机断层扫描(CT)是否与CTP成像效果相当。
对症状发作8小时内就诊、美国国立卫生研究院卒中量表(NIHSS)评分>7且拟进行血管内治疗的连续性前循环AIS患者进行前瞻性研究。所有患者均接受了非增强CT、CT血管造影和CTP检查。神经介入医生对CTP结果不知情,使用阿尔伯塔卒中项目早期CT评分(ASPECTS)做出治疗决策。收集患者的基线人口统计学资料、合并症和基线NIHSS评分。结局指标为出院时的改良Rankin量表(mRS)评分和住院死亡率。良好结局定义为mRS评分为0 - 2分。
283例AIS患者被纳入试验筛选,119例患者被纳入研究。其余患者因以下原因被排除:后循环卒中、未进行CTP检查、无法获得知情同意以及NIHSS评分<7。入院时平均NIHSS评分为16.8±3分,平均ASPECTS评分为8.4±1.4分。CTP半暗带与良好结局之间无统计学显著相关性:无半暗带者为50%,有半暗带者为47.8%(P = 0.85)。在无CTP半暗带证据的患者中,死亡率为22.5%,而有CTP半暗带的患者死亡率为22.1%。若ASPECTS≥7,64.6%的患者结局良好;若ASPECTS<7,则为13.3%(P< = 0.001)。ASPECTS≥7的患者死亡率为10%,而ASPECTS<7的患者死亡率为51.4%(P< = 0.001)。
当根据非增强CT的ASPECTS≥7选择患者时,CTP半暗带无法识别能从血管内治疗中获益的患者。CTP半暗带与良好结局或死亡率无关。需要进行更大规模的前瞻性试验,以证明在症状发作6小时内使用CTP的合理性。